Kukje Pharma Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seongnam Korea, Republic of (1959)
Status: No NME R&D (1959)

Organization Overview

First Clinical Trial
2016
NCT02967614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Kukje Pharma

Active Ingredients

Drugs in Phase 3 Trials (1)

ksr-001 (2 trials)

Drugs in Phase 2 Trials (3)

brimonidine (alphagan) (2 trials)

dorzolamide (trusopt) (2 trials)

timolol (blocadren) (2 trials)

Drugs in Phase 1 Trials (3)

irsogladine (1 trial)

ksr-004 (1 trial)

nizatidine (axid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eye Diseases (Phase 1)

Gastritis (Phase 1)

Ocular Hypertension (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 7